Clinical Trials - Company Evaluation Report, 2025

1.1 Market Definition
1.2 Stakeholders

3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Increasing Focus on Patient-Centric Trials (Dcts)
3.2.1.2 Increasing Clinical Trials for Precision/Personalized Medicines Supporting Growth in Clinical Trial Outsourcing
3.2.1.3 Rising R&D Investments and Patent Cliff Pressure Driving Growth in Outsourcing Clinical Trial Activities
3.2.1.4 Service Flexibility Offered by Cros for Clinical Development (Fsp, Fso, Hybrid)
3.2.1.5 Technological Integrations
3.2.2 Opportunities
3.2.2.1 Increased Focus on Pediatric Clinical Trials
3.2.2.2 Increasing Regulatory Requirements for Increasing Diversity in Clinical Trials
3.2.2.3 Growing Role of Real-World Evidence in Drug Approvals
3.2.2.4 Expanding Drug Modalities (Such as Cgt, Tissue Engineering, Bispecific ABS) in Clinical Trials
3.2.3 Challenges
3.2.3.1 Cybersecurity or Intellectual Property Concerns
3.2.3.2 Challenge of Patient Retention
3.2.3.3 Growing Market Competition
3.3 Market Trends
3.3.1 In Silico Clinical Trials
3.4 Trends/Disruptions Impacting Customer Business
3.5 Value Chain Analysis
3.6 Ecosystem Analysis
3.7 Technology Analysis
3.7.1 Key Technologies
3.7.1.1 Clinical Trial Management System (Ctms)
3.7.1.2 Electronic Data Capture (Edc) Systems
3.7.1.3 Randomization and Trial Supply Management (Rtsm)
3.7.2 Complementary Technologies
3.7.2.1 Telemedicine and Wearable Devices
3.7.2.2 AI and ML Integration
3.8 Key Conferences and Events, 2025-2026
3.9 Porter's Five Forces Analysis
3.9.1 Threat of New Entrants
3.9.2 Threat of Substitutes
3.9.3 Bargaining Power of Suppliers
3.9.4 Bargaining Power of Buyers
3.9.5 Intensity of Competitive Rivalry
3.10 Impact of AI/Gen AI on Clinical Trial Services Market
3.10.1 Introduction
3.10.2 Market Potential for Clinical Trials
3.10.3 AI Use Cases
3.10.4 Key Companies Implementing AI
3.10.5 Future of Generative AI in Clinical Trial Ecosystem

4.1 Overview
4.2 Key Player Strategies/Right to Win
4.3 Revenue Analysis
4.4 Market Share Analysis, 2024
4.5 Company Evaluation Matrix: Key Players, 2024
4.5.1 Stars
4.5.2 Emerging Leaders
4.5.3 Pervasive Players
4.5.4 Participants
4.5.5 Company Footprint: Key Players, 2024
4.5.5.1 Company Footprint
4.5.5.2 Region Footprint
4.5.5.3 Service Type Footprint
4.5.5.4 Phase Footprint
4.6 Company Evaluation Matrix: Startups/SMEs, 2024
4.6.1 Progressive Companies
4.6.2 Responsive Companies
4.6.3 Dynamic Companies
4.6.4 Starting Blocks
4.6.5 Competitive Benchmarking: Startups/SMEs, 2024
4.6.5.1 Detailed List of Key Startups/SMEs
4.6.5.2 Competitive Benchmarking of Startups/SMEs
4.7 Company Valuation and Financial Metrics
4.8 Brand/Service Comparison
4.9 Competitive Scenario
4.9.1 Service Launches
4.9.2 Deals
4.9.3 Expansions

5.1 Key Players
5.1.1 Iqvia Inc.
5.1.1.1 Business Overview
5.1.1.2 Services Offered
5.1.1.3 Recent Developments
5.1.1.3.1 Service Launches
5.1.1.3.2 Deals
5.1.1.3.3 Expansions
5.1.1.4 Analyst's View
5.1.1.4.1 Right to Win
5.1.1.4.2 Strategic Choices
5.1.1.4.3 Weaknesses and Competitive Threats
5.1.2 Icon PLC
5.1.2.1 Business Overview
5.1.2.2 Services Offered
5.1.2.3 Recent Developments
5.1.2.3.1 Service Launches
5.1.2.3.2 Deals
5.1.2.4 Analyst's View
5.1.2.4.1 Right to Win
5.1.2.4.2 Strategic Choices
5.1.2.4.3 Weaknesses and Competitive Threats
5.1.3 Thermo Fisher Scientific Inc.
5.1.3.1 Business Overview
5.1.3.2 Services Offered
5.1.3.3 Recent Developments
5.1.3.3.1 Service Launches
5.1.3.3.2 Deals
5.1.3.3.3 Expansions
5.1.3.4 Analyst's View
5.1.3.4.1 Right to Win
5.1.3.4.2 Strategic Choices
5.1.3.4.3 Weaknesses and Competitive Threats
5.1.4 Fortrea
5.1.4.1 Business Overview
5.1.4.2 Services Offered
5.1.4.3 Recent Developments
5.1.4.3.1 Service Launches
5.1.4.3.2 Deals
5.1.4.3.3 Expansions
5.1.4.4 Analyst's View
5.1.4.4.1 Right to Win
5.1.4.4.2 Strategic Choices
5.1.4.4.3 Weaknesses and Competitive Threats
5.1.5 Syneos Health
5.1.5.1 Business Overview
5.1.5.2 Services Offered
5.1.5.3 Recent Developments
5.1.5.3.1 Service Launches
5.1.5.3.2 Deals
5.1.5.4 Analyst's View
5.1.5.4.1 Right to Win
5.1.5.4.2 Strategic Choices
5.1.5.4.3 Weaknesses and Competitive Threats
5.1.6 Laboratory Corporation of America Holdings
5.1.6.1 Business Overview
5.1.6.2 Services Offered
5.1.6.3 Recent Developments
5.1.6.3.1 Service Launches
5.1.6.3.2 Deals
5.1.6.3.3 Expansions
5.1.6.4 Analyst's View
5.1.6.4.1 Right to Win
5.1.6.4.2 Strategic Choices
5.1.6.4.3 Weaknesses and Competitive Threats
5.1.7 Medpace
5.1.7.1 Business Overview
5.1.7.2 Services Offered
5.1.8 Wuxi Apptec
5.1.8.1 Business Overview
5.1.8.2 Services Offered
5.1.8.3 Recent Developments
5.1.8.3.1 Deals
5.1.9 Frontage Labs
5.1.9.1 Business Overview
5.1.9.2 Services Offered
5.1.9.3 Recent Developments
5.1.9.3.1 Deals
5.1.9.3.2 Expansions
5.1.10 Pharmaron
5.1.10.1 Business Overview
5.1.10.2 Services Offered
5.1.11 Tigermed
5.1.11.1 Business Overview
5.1.11.2 Services Offered
5.1.11.3 Recent Developments
5.1.11.3.1 Service Approvals
5.1.11.3.2 Deals
5.1.12 Sgs Société Générale De Surveillance SA
5.1.12.1 Business Overview
5.1.12.2 Services Offered
5.1.13 Eurofins Scientific
5.1.13.1 Business Overview
5.1.13.2 Services Offered
5.1.14 Linical
5.1.14.1 Business Overview
5.1.14.2 Services Offered
5.1.14.3 Recent Developments
5.1.14.3.1 Deals
5.1.14.3.2 Expansions
5.1.15 Parexel International Corporation
5.1.15.1 Business Overview
5.1.15.2 Services Offered
5.1.15.3 Recent Developments
5.1.15.3.1 Service Launches
5.1.15.3.2 Deals
5.1.15.3.3 Expansions
5.2 Other Players
5.2.1 Worldwide Clinical Trials
5.2.2 Propharma
5.2.3 Novotech
5.2.4 Psi
5.2.5 Allucent
5.2.6 Premier Research
5.2.7 Caidya
5.2.8 Ergomed Group
5.2.9 Clario
5.2.10 Precision Medicine Group, LLC.
5.2.11 Advanced Clinical
5.2.12 Eps Holdings, Inc.
5.2.13 Guires Inc. (Pepgra)
5.2.14 Kcr SA

6.1 Research Methodology
6.1.1 Research Data
6.1.1.1 Secondary Data
6.1.1.2 Primary Data
6.1.2 Research Assumptions
6.1.3 Research Limitations
6.2 Company Evaluation Matrix: Methodology

Table 1 Clinical Trial Services Market: Impact Analysis of Market Dynamics
Table 2 Clinical Trial Services Market: Role of Companies in Ecosystem
Table 3 Clinical Trial Services Market: Key Conferences and Events, 2025-2026
Table 4 Clinical Trial Services Market: Porter's Five Forces Analysis
Table 5 Overview of Strategies Adopted by Key Players in Clinical Trial Services Market, January 2021-January 2025
Table 6 Clinical Trial Services Market: Degree of Competition, 2024
Table 7 Clinical Trial Services Market: Region Footprint
Table 8 Clinical Trial Services Market: Service Type Footprint
Table 9 Clinical Trial Services Market: Phase Footprint
Table 10 Clinical Trial Services Market: Detailed List of Key Startup/SMEs
Table 11 Clinical Trial Services Market: Competitive Benchmarking of Key Startups/SMEs
Table 12 Clinical Trial Services Market: Service Launches, January 2021-January 2025
Table 13 Clinical Trial Services Market: Deals, January 2021-January 2025
Table 14 Clinical Trial Services Market: Expansions, January 2021-January 2025
Table 15 Iqvia Inc.: Company Overview
Table 16 Iqvia Inc.: Services Offered
Table 17 Iqvia Inc.: Service Launches, January 2021-January 2025
Table 18 Iqvia Inc.: Deals, January 2021-January 2025
Table 19 Iqvia Inc.: Expansions, January 2021-January 2025
Table 20 Icon PLC: Company Overview
Table 21 Icon PLC: Services Offered
Table 22 Icon PLC: Service Launches, January 2021-January 2025
Table 23 Icon PLC: Deals, January 2021-January 2025
Table 24 Thermo Fisher Scientific Inc.: Company Overview
Table 25 Thermo Fisher Scientific Inc.: Services Offered
Table 26 Thermo Fisher Scientific Inc.: Service Launches, January 2021-January 2025
Table 27 Thermo Fisher Scientific Inc.: Deals, January 2021-January 2025
Table 28 Thermo Fisher Scientific Inc.: Expansions, January 2021-January 2025
Table 29 Fortrea: Company Overview
Table 30 Fortrea: Services Offered
Table 31 Fortrea: Service Launches, January 2021-January 2025
Table 32 Fortrea: Deals, January 2021-January 2025
Table 33 Fortrea: Expansions, January 2021-January 2025
Table 34 Syneos Health: Company Overview
Table 35 Syneos Health: Services Offered
Table 36 Syneos Health: Service Launches, January 2021-January 2025
Table 37 Syneos Health: Deals, January 2021-January 2025
Table 38 Laboratory Corporation of America Holdings: Company Overview
Table 39 Laboratory Corporation of America Holdings: Services Offered
Table 40 Laboratory Corporation of America Holdings: Service Launches, January 2021-January 2025
Table 41 Laboratory Corporation of America Holdings: Deals, January 2021-January 2025
Table 42 Laboratory Corporation of America Holdings: Expansions, January 2021-January 2025
Table 43 Medpace: Company Overview
Table 44 Medpace: Services Offered
Table 45 Wuxi Apptec: Company Overview
Table 46 Wuxi Apptec: Services Offered
Table 47 Wuxi Apptec: Deals, January 2021-January 2025
Table 48 Frontage Labs: Company Overview
Table 49 Frontage Labs: Services Offered
Table 50 Frontage Labs: Deals, January 2021-January 2025
Table 51 Frontage Labs: Expansions, January 2021-January 2025
Table 52 Pharmaron: Company Overview
Table 53 Pharmaron: Services Offered
Table 54 Tigermed: Company Overview
Table 55 Tigermed: Services Offered
Table 56 Tigermed: Service Approvals, January 2021-January 2025
Table 57 Tigermed: Deals, January 2021-January 2025
Table 58 Sgs Société Générale De Surveillance SA: Company Overview
Table 59 Sgs Société Générale De Surveillance SA.: Services Offered
Table 60 Eurofins Scientific: Company Overview
Table 61 Eurofins Scientific: Services Offered
Table 62 Linical: Company Overview
Table 63 Linical: Services Offered
Table 64 Linical: Deals, January 2021-January 2025
Table 65 Linical: Expansions, January 2021-January 2025
Table 66 Parexel International Corporation: Company Overview
Table 67 Parexel International Corporation: Services Offered
Table 68 Parexel International Corporation: Service Launches, January 2021-January 2025
Table 69 Parexel International Corporation: Deals, January 2021-January 2025
Table 70 Parexel International Corporation: Expansions, January 2021-January 2025
Table 71 Worldwide Clinical Trials: Company Overview
Table 72 Propharma: Company Overview
Table 73 Novotech: Company Overview
Table 74 Psi: Company Overview
Table 75 Allucent: Company Overview
Table 76 Premier Research: Company Overview
Table 77 Caidya: Company Overview
Table 78 Ergomed Group: Company Overview
Table 79 Clario: Company Overview
Table 80 Precision Medicine Group, LLC: Company Overview
Table 81 Advanced Clinical: Company Overview
Table 82 Eps Holdings, Inc.: Company Overview
Table 83 Guires Inc. (Pepgra): Company Overview
Table 84 Kcr SA: Company Overview
Table 85 Risk Assessment

Figure 1 Clinical Trial Services Market, by Service Type, 2025 vs. 2030 (USD Million)
Figure 2 Clinical Trial Services Market, by Therapeutic Area, 2025 vs. 2030 (USD Million)
Figure 3 Clinical Trial Services Market, by Delivery Model, 2024 (USD Million)
Figure 4 Clinical Trial Services Market, by Modality, 2024 (USD Million)
Figure 5 Clinical Trial Services Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 6 Asia-Pacific to Register Highest CAGR in Clinical Trial Services Market During Forecast Period
Figure 7 Drivers, Opportunities, and Challenges in Clinical Trial Services Market
Figure 8 R&D Spend of Large Pharmaceutical Companies, 2014-2023 (USD Billion)
Figure 9 Biosimilar Approvals in US, 2015-2024
Figure 10 Number of Clinical Trials for Various Modalities
Figure 11 Trends/Disruptions Influencing Customer Business
Figure 12 Clinical Trial Services Market: Value Chain Analysis
Figure 14 Clinical Trial Services Market: Porter's Five Forces Analysis
Figure 15 Clinical Trial Services Market: Revenue Analysis of Key Players, 2022-2024 (USD Million)
Figure 16 Clinical Trial Services Market Share Analysis, 2024
Figure 17 Clinical Trial Services Market: Company Evaluation Matrix (Key Players), 2024
Figure 18 Clinical Trial Services Market: Company Footprint
Figure 19 Clinical Trial Services Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 20 Clinical Trial Services Market: Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors, 2024
Figure 21 Clinical Trial Services Market: EV/EBITDA of Key Vendors, 2024
Figure 22 Clinical Trial Services Market: Brand/Service Comparison
Figure 23 Iqvia Inc.: Company Snapshot (2024)
Figure 24 Icon PLC: Company Snapshot (2023)
Figure 25 Thermo Fisher Scientific Inc.: Company Snapshot (2023)
Figure 26 Fortrea: Company Snapshot (2023)
Figure 27 Laboratory Corporation of America Holdings: Company Snapshot (2023)
Figure 28 Medpace: Company Snapshot (2024)
Figure 29 Wuxi Apptec: Company Snapshot (2023)
Figure 30 Frontage Labs: Company Snapshot (2023)
Figure 31 Pharmaron: Company Snapshot (2023)
Figure 32 Tigermed: Company Snapshot (2023)
Figure 33 Sgs Société Générale De Surveillance SA: Company Snapshot (2023)
Figure 34 Eurofins Scientific: Company Snapshot (2024)
Figure 35 Linical: Company Snapshot (2023)
Figure 36 Research Design